Please use this identifier to cite or link to this item:
Scopus Web of Science® Altmetric
Type: Journal article
Title: Inflammation in acute CNS injury: a focus on the role of substance P
Author: Corrigan, F.
Vink, R.
Turner, R.
Citation: British Journal of Pharmacology, 2016; 173(4):703-715
Publisher: Wiley
Issue Date: 2016
ISSN: 0007-1188
Statement of
F Corrigan, R Vink, and R J Turner
Abstract: Recently, a number of reports have shown that neurogenic inflammation may play a role in the secondary injury response following acute injury to the CNS, including traumatic brain injury (TBI) and stroke. In particular substance P (SP) release appears to be critically involved. Specifically, the expression of the neuropeptide SP is increased in acute CNS injury, with the magnitude of SP release being related to both the frequency and magnitude of the insult. SP release is associated with an increase in blood-brain barrier permeability and the development of vasogenic oedema as well as neuronal injury and worse functional outcome. Moreover, inhibiting the actions of SP through use of a NK1 receptor antagonist is highly beneficial in both focal and diffuse models of TBI, as well as in ischaemic stroke, with a therapeutic window of up to 12 h. We propose that NK1 receptor antagonists represent a novel therapeutic option for treatment of neurogenic inflammation following acute CNS injury.
Keywords: Central Nervous System; Animals; Humans; Inflammation; Substance P; Neurokinin-1 Receptor Antagonists
Rights: © 2015 The British Pharmacological Society
RMID: 0030026161
DOI: 10.1111/bph.13155
Appears in Collections:Medicine publications

Files in This Item:
File Description SizeFormat 
hdl_99980.pdfAccepted version428.41 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.